Skip to main content
. Author manuscript; available in PMC: 2022 Jun 8.
Published in final edited form as: J Allergy Clin Immunol Pract. 2020 Dec 5;9(2):1008–1010.e2. doi: 10.1016/j.jaip.2020.11.050

FIGURE 2.

FIGURE 2.

Percentage of cells expressing STAT5B N642H genomic DNA determined by targeted droplet digital PCR (ddPCR) in sorted leukocyte lineages before and after ruxolitinib in patients A and B. Percentages of cells expressing the variant are calculated as measured allelic frequency observed × 2. NK, Natural killer.